Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co’s Jürgen Polifka joins Cardiome

Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess

Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and marketing Europe.

Polifka was most recently regional marketing leader hospital care at Merck for a portfolio of products, including atrial fibrillation treatment Brinavess (vernakalant), which Cardiome is due to assume commercialisation responsibility for in Europe.

In total, Polifka spent more than 16 years at Merck, serving in several senior roles, such as product manager, marketing and sales manager, director hospital and specialty products and brand leader. During this time, he covered both infectious disease and cardiovascular care at different stages.

"We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer.

"His personal experience with Brinavess at MSD and deep understanding of the European hospital and cardiovascular markets will be invaluable as Cardiome assumes commercialisation responsibility for Brinavess in Europe."

9th April 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics